Work

ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical Worsening

Year: 2021

Type: article

Study design: Observational Study

Source: CHEST Journal

DOI: 10.1016/j.chest.2021.01.085

Authors: Megan Griffiths, Jun Yang, Catherine E. Simpson, Dhananjay Vaidya, Melanie Nies, Stephanie Brandal, Rachel Damico, D. Dunbar Ivy, Eric D. Austin, Michael W. Pauciulo, Katie A. Lutz, Erika B. Rosenzweig, Russel Hirsch, Delphine Yung, William C. Nichols, Allen D. Everett

Institutions: Johns Hopkins University, Children's Hospital Colorado, Vanderbilt University Medical Center, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Columbia University Irving Medical Center, Columbia University, University of Washington

Language: English

Topic: Pulmonary Hypertension Research and Treatments

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Center for Research Resources, National Center for Advancing Translational Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: G1441675580, Role of IGF axis in pulmonary hypertension, G1898711858, G2047902840, Clinical and mechanistic role of HDGF in pulmonary hypertension, G3167883762, The role of xanthine oxidoreductase activity and altered metabolism in scleroderma-associated pulmonary arterial hypertension, G475936976, Uric Acid and its Genetic Regulators as Biomarkers of Pulmonary Arterial Hypertension in Scleroderma, G5033267147, G6158508021, General Clinical Research Center, Pulmonary Hypertension Breakthrough Initiative, Colorado Clinical and Transational Sciences Institute, G9000009745, G9000030435, G985156306, Colorado Clinical and Translational Science Institute (UL1)

OpenAlex ID: W3132497654

FWCI: 1.778

Cites: 24

Cited by: 24

Related to: 10